ArticleCardiovascular research2025
Integrated proteomics identifies troponin I isoform switch as a regulator of a sarcomere-metabolism axis during cardiac regeneration.
Article in Cardiovascular research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Signaling pathways regulating cardiac regeneration.Cell regeneration (London, England) · 2026Review
- Relationship between cardiac troponin and myocardial infarction: a bibliometric analysis.Journal of cardiothoracic surgery · 2026Article
- Cardiomyocyte maturation and proliferation is a flip coin.BMC cardiovascular disorders · 2025Review
Corrections and comments
- Commented on by
- Update of
Authors and funding
11 authors.
Funding
Abstract
aimsAdult mammalian cardiomyocytes (CMs) have limited regenerative potential, and after myocardial infarction (MI), injured cardiac tissue is replaced with fibrotic scar. In contrast, the neonatal mouse heart possesses a regenerative capacity governed by CM proliferation; however, a metabolic switch from glycolysis to fatty acid oxidation during post-natal development results in loss of this regenerative capacity. Interestingly, a sarcomere isoform switch also takes place during post-natal development where slow skeletal troponin I (ssTnI) is replaced with cardiac troponin I (cTnI). It remains unclear whether there is an interplay between sarcomere isoform switching, cardiac metabolism, and regeneration. METHODS AND
resultsIn this study, we employ proteomics, metabolomics, and lipidomics, transgenic mice, MI models, and histological analysis to delineate the molecular and sarcomeric transitions that occur during cardiac maturation and regeneration. First, we utilize integrated quantitative bottom-up and top-down proteomics to comprehensively define the proteomic and sarcomeric landscape during post-natal heart maturation. By employing a CM-specific ssTnI transgenic mouse model, we discovered that ssTnI overexpression increased CM proliferation and the cardiac regenerative capacity of the post-natal heart following MI compared to control mice by histological analysis. Our global proteomic analysis of ssTnI transgenic mice following MI reveals that ssTnI overexpression induces a significant shift in the cardiac proteomic landscape. Additionally, our lipidomic analysis demonstrated a significant up-regulation of lipid species in the transgenic mice. This proteomic shift is characterized by an up-regulation of key proteins involved in glycolytic metabolism.
conclusionCollectively, our data suggest that the post-natal TnI isoform switch may play a role in the metabolic shift from glycolysis to fatty acid oxidation during post-natal maturation. This underscores the significance of a sarcomere-metabolism axis during CM proliferation and heart regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.